Oriana Jimena López Godino

Bento L, Gutierrez A, Novelli S, Montoro J, Pinana JL, Lopez-Corral L, Cabrero M, Martin-Sancho A, Gutierrez-Garcia G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Perez A, Hernani R, Ferra C, Parody R, Garcia-Cadenas I, Herrera P, Rodriguez G, Rodriguez N, Martin C, Yanez L, Zanabili J, Varela MR, Lopez-Godino O, Heras I, Espanol I, Martinez C, Perez-Simon JA, Solano C, Sureda A, Sierra J, Sampol A, Caballero D; Grupo Espanol de Trasplante Hematopoyetico (GETH) and Grupo Espanol de Linfoma y Trasplante Autologo (GELTAMO). Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study. Bone Marrow Transplant. 2021 Aug;56(8):1919-1928. doi: 10.1038/s41409-021-01264-3. Epub 2021 Mar 25. PubMed PMID: 33767400.

AÑO: 2021; IF: 5.174

33767400

Parra Salinas I, Bermudez A, Lopez Corral L, Lopez Godino O, Moles-Poveda P, Martin G, Costilla Barriga L, Ferra Coll C, Marquez-Malaver F, Orti G, Zudaire Ripa MT, Rifon J, Martinez C; Spanish Group of Hematopoietic Transplantation (GETH). Treatment of steroid-refractory chronic graft-versus-host disease with imatinib: Real-life experience of the Spanish group of hematopoietic transplantation (GETH). Clin Transplant. 2021 May;35(5):e14255. doi: 10.1111/ctr.14255. Epub 2021 Mar 1. PubMed PMID: 33595866.

AÑO: 2021; IF: 3.456

33595866

Novelli S, Bento L, Garcia I, Prieto L, Lopez L, Gutierrez G, Hernani R, Perez A, Esquirol A, Solano C, Bastos M, Dorado N, Rodriguez N, Rodriguez G, Pinana JL, Montoro J, Herrera P, Luna A, Parody R, Martin C, Garcia E, Lopez O, Heras I, Zanabili J, Moraleda JM, Yanez L, Gutierrez A, Zudaire T, Cordoba R, Varela R, Ferra C, Martinez J, Martinez C, Gonzalez-Barca E, Martino R, Caballero D; GELTAMO and GETH. Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers. Transplant Cell Ther. 2021 Jun;27(6):493.e1-493.e8. doi: 10.1016/j.jtct.2021.03.014. Epub 2021 Mar 15. PubMed PMID: 33857447.

AÑO: 2021; IF: 0.0

33857447

Hernandez-Boluda JC, Pereira A, Alvarez-Larran A, Martin AA, Benzaquen A, Aguirre L, Mora E, Gonzalez P, Mora J, Dorado N, Sampol A, Garcia-Gutierrez V, Lopez-Godino O, Fox ML, Reguera JL, Perez-Encinas M, Pascual MJ, Xicoy B, Parody R, Gonzalez-Pinedo L, Espanol I, Avendano A, Correa JG, Vallejo C, Jurado M, Garcia-Cadenas I, Osorio S, Duran MA, Sanchez-Guijo F, Cervantes F, Pinana JL. Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model. Biol Blood Marrow Transplant. 2020 Dec;26(12):2237-2244. doi: 10.1016/j.bbmt.2020.07.022. Epub 2020 Jul 24. PubMed PMID: 32717433.

AÑO: 2020; IF: 5.742

32717433

Carrillo-Cruz E, Garcia-Lozano JR, Marquez-Malaver FJ, Sanchez-Guijo FM, Montero Cuadrado I, Ferra I Coll C, Valcarcel D, Lopez-Godino O, Cuesta M, Parody R, Lopez-Corral L, Alcoceba M, Caballero-Velazquez T, Rodriguez-Gil A, Bejarano-Garcia JA, Ramos TL, Perez-Simon JA. Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms. Clin Cancer Res. 2019 Aug 1;25(15):4616-4623. doi: 10.1158/1078-0432.CCR-18-3875. Epub 2019 May 1. PubMed PMID: 31043390.

AÑO: 2019; IF: 10.107

31043390